Long-term experience with continuous duodenal levodopa-carbidopa infusion (Duodopa): report of six patients.
Raudino
F
F
Garavaglia
P
P
Pianezzola
C
C
Riboldazzi
G
G
Leva
S
S
Guidotti
M
M
Bono
G
G
D000368:Aged; D000978:Antiparkinson Agents / Q000008:administration & dosage*; D002230:Carbidopa / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004386:Duodenum / Q000187:drug effects / Q000378:metabolism; D004409:Dyskinesia, Drug-Induced / Q000517:prevention & control; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007260:Infusion Pumps / Q000706:statistics & numerical data*; D007980:Levodopa / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D013995:Time; D013997:Time Factors; D016896:Treatment Outcome
D000978:Antiparkinson Agents; D007980:Levodopa; D002230:Carbidopa